Discovery of a Cox-2 Selective Inhibitor Hit with Anti-Inflammatory Activity and Gastric Ulcer Protective Effect

Abstract

In addition, docking study of the most potent and selective compound 12h into COX-2 active site revealed that this target compound assumed interactions and binding pattern similar to that of as a cocrystallized ligand bromocelecoxib (S-58).